Vical, Inc. (NASDAQ:VICL)

CAPS Rating: 3 out of 5

The Company researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases.

Recs

0
Player Avatar BicaChica (77.57) Submitted: 9/29/2010 10:11:54 PM : Outperform Start Price: $2.26 VICL Score: +11.29

tenmiles

Featured Broker Partners


Advertisement